Treatment of Periorbital Cellulitis
High-dose amoxicillin-clavulanate is the first-line treatment for periorbital cellulitis, providing comprehensive coverage against the most common causative organisms. 1
Causative Organisms and Antibiotic Selection
- Periorbital cellulitis is most commonly caused by Streptococcus species (particularly group A streptococci) and Staphylococcus aureus 2
- Sinusitis (43%) is the most frequent predisposing condition, followed by trauma (25%) and odontogenic infections (6%) 3
- For empiric therapy, antibiotics should cover both streptococci and staphylococci 2
Treatment Algorithm
Mild Cases (Outpatient Management)
- For mild cases with eyelid less than 50% closed, outpatient treatment with high-dose amoxicillin-clavulanate is appropriate 1
- Alternative oral options include:
- Treatment duration typically ranges from 5-7 days, but should be extended if infection has not resolved 1
- Daily follow-up is necessary until definite improvement is noted 1
Moderate to Severe Cases (Inpatient Management)
- Hospitalization criteria include:
- Parenteral therapy options include:
Special Considerations
- MRSA Coverage: If MRSA is suspected based on local prevalence or risk factors, appropriate coverage should include vancomycin, clindamycin, trimethoprim-sulfamethoxazole, or doxycycline 1
- Penicillin Allergy: For patients with severe penicillin allergies, clindamycin or vancomycin are appropriate alternatives 2
- Imaging: CT scan with IV contrast is the most useful imaging modality to differentiate preseptal from postseptal involvement and identify potential complications 1, 6
- Surgical Intervention: While most cases respond to antibiotics alone, approximately 6% of patients may require surgical intervention, particularly for drainage of abscesses or management of extensive sinus disease 5, 6
Monitoring and Follow-up
- Patients with mild cases treated as outpatients should be reassessed within 24-48 hours 1
- For hospitalized patients, daily assessment is necessary to monitor response to therapy 1
- Some centers have successfully implemented daily outpatient IV antibiotic administration with physician evaluation as an alternative to admission for select cases 7
Common Pitfalls
- Failing to distinguish between periorbital (preseptal) and orbital (postseptal) cellulitis, which requires different management approaches 6
- Not considering MRSA coverage when risk factors are present 1
- Inadequate duration of therapy or failure to reassess response after initial treatment 1
- Delaying appropriate imaging in cases with concerning features such as proptosis, visual changes, or ophthalmoplegia 1